Question 1

What is the catalog number for CP-724714 (b)?

Accepted Answer

The catalog number for CP-724714 (b) is M14915.

Question 2

What sizes are available for CP-724714 (b)?

Accepted Answer

CP-724714 (b) is available in the following size(s): 1 g, 200 mg, 500 mg, 5 mg, 50 mg, 100 mg.

Question 3

How many pack sizes does CP-724714 (b) come in?

Accepted Answer

CP-724714 (b) is available in 6 different pack sizes.

Question 4

Is CP-724714 (b) in stock?

Accepted Answer

CP-724714 (b) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is CP-724714 (b) used for?

Accepted Answer

CP-724714 is a potent, selective inhibitor of HER2/ErbB2 with IC50 of 10 nM.

Question 6

What temperature does this product ship at?

Accepted Answer

Shipping temperature is chosen based on the product’s stability needs, ranging from ambient to dry ice, and is indicated on the product page. Any related shipping fee is shown clearly in your quotation.

Question 7

What is the molecular weight of the target protein?

Accepted Answer

Molecular weight information, where applicable, is listed on the datasheet under target details, useful for confirming the correct band on western blot.

Question 8

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

CP-724714 (b)

Product Specifications

CAS Number

Stability

Purity

Weight

Molecular Formula

Notes

Receptor

Available Sizes

Frequently Asked Questions

Explore Other Products

Phospho-Parkin (Ser65) Blocking Peptide

Phospho-Parkin (Ser65) Blocking Peptide

Biotin-Linked Polyclonal Antibody to Alpha-Fetoprotein (AFP)

Biotin-Linked Polyclonal Antibody to Alpha-Fetoprotein (AFP)

35 μm aperture DT MicroLoops LD

CBu-Cit-GAL-02-221